Mylan Laboratories Inc. (NYSE: MYL) announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 40 mg. Fluoxetine Capsules are the generic version of Eli Lilly and Company’s Prozac(R) Capsules. Fluoxetine Capsules had U.S. [click link for full article]
Popularity: unranked [?]
